Amrutanjan Health Care FY26 Results: PAT rises 14% to ₹57.92 crore
- Amrutanjan Health Care reported FY26 PAT of ₹57.92 crore, up 13.93% YoY, on revenue from operations of ₹502.55 crore, up 11.23% YoY
- EBITDA grew 14.82% to ₹66.83 crore with margin expanding to 13.30% from 12.88% in FY25
- Pain management recorded 10% gross sales growth and Women's Hygiene brand Comfy posted 19% gross sales growth, with gross revenue reaching ₹151.31 crore
- Quick Commerce channel grew 84.2% to ₹7.55 crore and Export revenue rose 36.1% to ₹11.15 crore in FY26
- Board recommended a final dividend of ₹2.90 per share for FY26; total dividend for the year stands at ₹4.90 per share
*this image is generated using AI for illustrative purposes only.
Amrutanjan Health Care Limited posted a Profit After Tax of ₹57.92 crore for FY26, up 13.93% from ₹50.83 crore in FY25, on gross sales of ₹559.56 crore against ₹509.68 crore a year earlier.
Revenue from operations grew 11.23% to ₹502.55 crore in FY26 from ₹451.82 crore in FY25. EBITDA rose to ₹66.83 crore from ₹58.20 crore, with EBITDA margin expanding to 13.30% from 12.88%. Profit Before Tax stood at ₹77.89 crore, up from ₹69.13 crore. The Board has recommended a final dividend of ₹2.90 per equity share for FY26, taking total dividend to ₹4.90 per share including two interim dividends of ₹1 each.
Key Financial Metrics
The table below captures FY26 performance against FY25 across headline indicators.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Gross Sales | ₹559.56 cr | ₹509.68 cr | +9.8% |
| Revenue from Operations | ₹502.55 cr | ₹451.82 cr | +11.23% |
| EBITDA | ₹66.83 cr | ₹58.20 cr | +14.82% |
| EBITDA Margin | 13.30% | 12.88% | +42 bps |
| Profit Before Tax | ₹77.89 cr | ₹69.13 cr | +12.66% |
| Profit After Tax | ₹57.92 cr | ₹50.83 cr | +13.93% |
| Basic EPS | ₹20.03 | ₹17.58 | +13.94% |
| Net Worth | ₹370.23 cr | ₹326.61 cr | — |
| Dividend Per Share | ₹4.90 | ₹4.60 | — |
| Return on Capital Employed | 21.40% | 21.44% | — |
Segment Performance
The OTC Products segment reported net sales of ₹32,831.73 lakhs in FY26 against ₹29,002.99 lakhs in FY25, with segment results of ₹8,344.36 lakhs. The Women's Hygiene and Personal Care segment recorded net sales of ₹13,990.66 lakhs versus ₹12,396.25 lakhs, though segment results remained negative at ₹(272.16) lakhs, an improvement from ₹(391.05) lakhs in FY25. The Beverages segment posted net sales of ₹3,156.09 lakhs against ₹3,643.01 lakhs, with segment results of ₹(634.86) lakhs.
| Segment | Net Sales FY26 (₹ lakhs) | Net Sales FY25 (₹ lakhs) | Segment Result FY26 (₹ lakhs) |
|---|---|---|---|
| OTC Products | 32,831.73 | 29,002.99 | 8,344.36 |
| Women's Hygiene & Personal Care | 13,990.66 | 12,396.25 | (272.16) |
| Beverages | 3,156.09 | 3,643.01 | (634.86) |
Brand and Category Growth
Pain management recorded 10% gross sales growth in FY26. Within the headache category, Head Roll-On sales grew 21%, with larger SKUs of 27.5 ml and 50 ml growing 17% and the 8 ml pack growing 4%. In the body ache category, Maha Strong grew 22% and Back Pain Roll-On grew 12%. The Relief congestion range recorded 9% gross sales growth, with Relief Inhaler up 16% and Relief Rubs up 15%.
Comfy, the Women's Hygiene brand, recorded 19% gross sales growth in FY26. The XL variant grew 44% and the 18-unit Value Pack grew 42%. The XL variant's contribution to overall Comfy sales rose from 31% in FY25 to 37% in FY26. The Women's Hygiene category achieved gross revenue of ₹151.31 crore in FY26, compared with ₹127.79 crore in FY25.
Revenue Contribution by Product Range
| Revenue Band | Product |
|---|---|
| ₹150 cr+ | Comfy Range |
| ₹100 cr – ₹150 cr | 8 ml Yellow and White Balm |
| ₹50 cr – ₹100 cr | Head Roll On |
| ₹25 cr – ₹50 cr | Enerlyte / Electro+ & 1 ml Balm |
Digital and Export Channels
The E-commerce channel recorded revenue of ₹14.12 crore in FY26, registering growth of 48.8% over the previous year. The Quick Commerce channel recorded revenue of ₹7.55 crore, representing growth of 84.2% over the previous year. Export revenue reached ₹11.15 crore in FY26, up 36.1% over the previous year, with Africa accounting for 81% of total exports.
Manufacturing Investment
Amrutanjan commissioned a Greenfield Sanitary Napkin Manufacturing Facility at Seetharampur Village, Rangareddy District, Telangana. The ₹150 crore investment covers 10 acres with a 1.40 lakh sq. ft. built-up area and features two fully automated high-speed production lines from Japan, with a planned annual production capacity of 700 million sanitary napkins. The facility is expected to generate 200 direct and 150 indirect employment opportunities.
Distribution and Operational Highlights
| Indicator | FY26 vs FY25 Change |
|---|---|
| Sales Infrastructure (Stockist network) | +9% |
| Total Direct Outlets Covered | +12% |
| Effective Outlets Coverage | +7% |
| Productive Calls | +6% |
| Sales Man Productivity | +8% |
| Total Lines Sold | +35% |
The Company added 44,000 new chemist outlets during FY26 and plans to add 1,00,000 chemists by FY2027. Total distribution reach expanded to 1.12 million retail outlets across India. The network comprised 3,994 distributors and sub-distributors as of FY26.
CSR Spend
Total CSR spend in FY26 was ₹1,29,18,087.08, exceeding the mandatory obligation of ₹1,23,15,040.80. Initiatives spanned education, health and sanitation, animal welfare, and environmental sustainability across multiple states.
Five-Year Financial Trend
| Fiscal Year | Revenue from Operations (₹ cr) | EBITDA (₹ cr) | PAT (₹ cr) | Basic EPS (₹) |
|---|---|---|---|---|
| FY22 | 405.84 | 79.47 | 67.19 | 23.00 |
| FY23 | 379.64 | 44.39 | 39.83 | 13.65 |
| FY24 | 421.23 | 51.81 | 44.97 | 15.50 |
| FY25 | 451.82 | 58.20 | 50.83 | 17.58 |
| FY26 | 502.55 | 66.83 | 57.92 | 20.03 |
How will the ₹150 crore greenfield sanitary napkin facility impact Amrutanjan's cost structure and market share in the Women's Hygiene segment by FY27?
Given the continued losses in the Beverages and Women's Hygiene segments, what strategic steps is management taking to achieve profitability in these units?
Can the rapid 84% growth in Quick Commerce revenue be sustained as the channel matures, and what percentage of total sales does management target for digital channels in the next three years?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
